Leppert, W. (2014). Oxycodone/naloxone in the management of patients with pain and opioid-induced bowel dysfunction. Current Drug Targets, 15, 124-135.
PHASE OF CARE: Multiple phases of care
APPLICATIONS: Palliative care
Oxycodone plus naloxone (OXN) appeared to provide similar analgesic effects as oxycodone, but it also improved bowel function, defined as more frequent and complete spontaneous bowel movements and less consumption of laxatives. In addition, OXN improved the passing of urine in patients with postoperative pain while reducing OIBD, improving compliance, and enhancing quality of life. OXN may be administered to opioid-naïve patients with moderate to severe pain and to patients not responding to weak opioids. The evidence from studies of chronic nonmalignant and cancer-related pain demonstrated the role of OXN in the prevention and treatment of OIBD in patients who required opioid therapy for moderate to severe pain. An evaluation of the value of the literature and studies was not evident in this article.
OIBD is a common complication in patients receiving long-term opioid treatment. The use of OXN was demonstrated by a number of studies to be effective for the management of pain and to have a role in the prevention of OIBD in patients with moderate to severe chronic nonmalignant and cancer-related pain.
Demographic characteristics were generally well-balanced between OXN groups and placebo or oxycodone groups. However, there was a larger sample size of patients with cancer-related pain in one specific study that could have altered the results. There was a high rate of variability in the type of studies that were included, and there was no critical analysis of the literature.
OXN appears to provide similar analgesic effects as oxycodone, but it improves bowel function, defined as more frequent and complete spontaneous bowel movements and a less frequent consumption of laxatives. In addition, patients receiving OXN had improved quality of life scores with decreased OIBD complications.
Leow, M., Chan, S., & Chan, M. (2015). A pilot randomized, controlled trial of the effectiveness of a psychoeducational intervention on family caregivers of patients with advanced cancer. Oncology Nursing Forum, 42, E63–E72.
To evaluate the efficacy of the Caring for the Caregiver Program (CCP) to enhance the quality of life of the caregivers of patients diagnosed with advanced cancer compared to caregivers who receive standard care
Participants were randomized to receive the intervention using CCP plus standard care or standard care from home Hospice providers. Two post-test measures were used at four and eight weeks postintervention. The CCP intervention was comprised of a one-hour, face-to-face session to develop a plan of care, a video clip, two follow-up phone calls, and an invitation to join an online social support group.
Pilot-randomized, controlled trial with a two-group pretest and repeated post-test
The CCP had a positive effect on family caregivers providing care to patients with advanced cancer.
Identifying at-risk caregivers and implementing a CCP intervention can improve the experience of patients with an advanced diagnosis of cancer and their caregivers. These types of interventions have the potential to decrease caregiver strain and burden by improving access to social supports and improving knowledge and self-efficacy.
Leonardi, M.C., Gariboldi, S., Ivaldi, G.B., Ferrari, A., Serafini, F., Didier, F., . . . Orecchia, R. (2008). A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: Interim analysis. European Journal of Dermatology, 18, 317–321.
To assess the efficacy of MASO65D (Xclair™) in managing radiation dermatitis (RD) during radiation therapy and the follow-up period
Patients were randomized to use of MASO65D or the control cream. The control vehicle was an emollient-based cream that was similar in color and consistency but did not contain key ingredients. Patients had to observe a washout period of seven days. Patients were also instructed to apply study cream on the irradiated area three times daily, starting on first day of irradiation and continuing until three weeks after completion of radiation therapy. Patients were examined at weekly intervals during radiation therapy and three weeks after its completion.
The study took place at the European Institute of Oncology in Milan, Italy.
The study used a randomized double-blind vehicle-controlled design.
The study demonstrated a statistically significant difference between vehicle and MAS065D groups regarding the maximum severity of skin toxicity (p < 0.0001), symptoms of burning within the radiation field (p = 0.039), and desquamation (p = 0.02). In the MAS065D group, 13.5% reported mild-to-moderate desquamation, compared with 50% in the vehicle group. A higher proportion of the experimental group had no desquamation. The most significant differences between the two groups were recorded after three weeks of treatment. Both study creams were well tolerated for their cosmetic acceptability. No adverse events were observed or reported in either group of patients who completed the study.
MAS065D had a significantly better outcome with prevention and treatment of skin reactions.
León-Pizarro, C., Gich, I., Barther, E., Rovirosa, A., Farrús, B., Casas, F., . . . Arcusa, A. (2007). A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and quality-of-life indices for gynecologic and breast brachytherapy patients. Psycho-Oncology, 16, 971–979.
The intervention consisted of relaxation and guided imagery provided to patients during hospitalization. The intervention group received training in relaxation and guided imagery for 10 minutes and was given an individualized cassette for use at home and at the hospital. The recording on the cassette consisted of instructions on head-to-toe relaxation and breathing techniques. Patients were then given descriptions of pleasing images (mountains, beach, etc.) based on information gathered from the patients prior to recording of the cassette. Patients in both groups received training regarding brachytherapy, but only study group patients received training in relaxation and guided imagery.
Two hospitals in Spain
A randomized controlled trial design was used.
The intervention group demonstrated a statistically significant reduction in anxiety (p = 0.008) compared with the control group.
Lennernas, B., Frank-Lissbrant, I., Lennernas, H., Kalkner, K.M., Derrick, R., & Howell, J. (2010). Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: Results from a randomized phase II study. Palliative Medicine, 24(3), 286–293.
To evaluate the efficacy and tolerability of sublingual fentanyl for the treatment of breakthrough pain in opioid-tolerant cancer patients
This study was conducted from July 2002 to January 2004 at five university clinics in Sweden. Patients had locally advanced or metastatic cancer and were currently
Each patient received, at four pain episodes occurring between 0700 and 1600 (defined as the treatment period), a placebo dose and 100, 200, and 400 mcg doses of sublingual fentanyl. The doses were provided in a random order, according to a computer-generated randomization list. At least one day fell between each treatment period, to avoid carry-over effects. Patients were asked to rate their pain at the onset of an episode of breakthrough pain and then at 5, 10, 15, 20, and 30 minutes postingestion of the study drug. At 60 minutes, the patients were asked to make a global assessment of the treatment by using a four-point scale.
Randomized, multicenter double-blind, four-period crossover study
Twenty-three patients completed all four treatment doses. Twenty-two of the 23 patients (95%) reported that at least one dose of the sublingual fentanyl produced a clinically important decrease in pain intensity, as measured by a decrease in pain intensity of more than 20 mm on the VAS. In regard to adverse events, 13 patients reported 15 adverse events considered to be related to the study drug. The most common treatment-related adverse effects were nausea and dizziness. Increasing the doses of sublingual fenanyl did not appear to increase the number or severity of adverse events, when evaluated related to increasing doses of sublingual fentanyl.
Within 15 minutes of administration, 400 micrograms of sublingual fentanyl proved more effective than placebo at significantly improving overall pain intensity difference. This was true over the entire treatment period. In regard to reducing pain intensity, results showed that the 100 and 200 mcg doses of sublingual fentanyl were more effective than placebo.
Further study is needed to determine, in regard to decreasing breakthrough pain, the efficacy of each of the doses of sublingual fentanyl.
Lengacher, C.A., Reich, R.R., Paterson, C.L., Jim, H.S., Ramesar, S., Alinat, C.B., . . . Kip, K.E. (2015). The effects of mindfulness‐based stress reduction on objective and subjective sleep parameters in women with breast cancer: A randomized controlled trial. Psycho‐Oncology, 24, 424–432.
To investigate the effects of mindfulness-based stress reduction (MBSR) on sleep parameters in women with breast cancer
Patients were randomized to the MBSR group or a usual care wait-list control group. MBSR was delivered in two-hour weekly sessions six times, including educational materials related to relaxation, meditation, healthy lifestyle, practice of meditation, yoga, body scan and walking meditation, and supportive group interaction and discussion. Patients were asked to practice meditative techniques 15–45 minutes daily. Study measures were obtained at baseline, six weeks, and 12 weeks.
Randomized, controlled trial
From baseline to six weeks, there were no differences between the groups. From 6–12 weeks, there were improvements in the MBSR group in sleep efficiency and the number of times patients awoke as measured by actigraphy (between groups Cohen’s d = 0.33 – 0.38; p = 0.04; p < 0.01). There were no differences between groups in PSQI or sleep diary findings. Sleep efficiency, the percent of time per night in sleep, was 78.2% in the MBSR group compared to 74.6% in the control group. All sleep parameters improved in both groups. There was no correlation between how much individuals practiced and sleep outcomes.
The use of MBSR resulted in improvements in some sleep parameters.
The findings of this study suggest that MBSR as provided in this intervention might improve some sleep parameters compared to usual care control patients; however, sleep parameters did improve over time in all participants. This is a low-risk type of intervention, but it involves multiple sessions delivered in person. It is not known whether different delivery methods can be successful, what the appropriate and necessary timing should be, or what the frequency and duration of the delivered interventions should be.
Lengacher, C. A., Reich, R. R., Post-White, J., Moscoso, M., Shelton, M. M., Barta, M., . . . Budhrani, P. (2012). Mindfulness based stress reduction in post-treatment breast cancer patients: an examination of symptoms and symptom clusters. Journal of Behavioral Medicine, 35, 86–94.
To compare the prevalence and severity of symptoms and symptom clusters in patients with breast cancer who participated in a mindfulness-based stress reduction (MBSR) program to the symptoms and symptom clusters in patients who received usual care.
Women who expressed interest in participating in the study were randomly assigned to MBSR or usual care. The MBSR program lasted six weeks and included educational material, meditation practice in weekly group settings and homework, group discussion on barriers to meditation, application of mindfulness in daily life, and group support interactions. Meditation training consisted of sitting and walking meditation, body scan, and gentle Hatha yoga. Researchers obtained study measures at baseline and within two weeks of program conclusion. Hierarchical-cluster analysis was used to identify symptom clusters. Researchers compared each group's symptom clusters and individual symptoms to those of the other group.
This was a randomized, controlled trial.
MD Anderson Symptom Inventory
Severity of symptoms declined in both groups from baseline to the end of the study. Fatigue and drowsiness declined more in the MBSR group (p = 0.05). Interference scores for mood and relationships also declined more in the MBSR group (p ≤ 0.05). Analysis of changes in symptom clusters showed no differences between groups. Clusters identified were gastrointestinal (nausea, vomiting, anorexia, shortness of breath, dry mouth, numbness), cognitive or psychological (distress, sadness, pain, remembering), and fatigue (fatigue, disturbed sleep, drowsiness). Cluster scores declined in both groups.
Findings suggested that MBSR interventions may benefit women with breast cancer who are managing fatigue or mood.
Findings suggested that MBSR may be helpful, to some patients with breast cancer, as a means of combating fatigue and mood changes. Study limitations limited the strength of these findings.
Lengacher, C.A., Johnson-Mallard, V., Post-White, J., Moscoso, M.S., Jacobsen, P.B., Klein, T.W., … Kip, K.E. (2009). Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psycho-Oncology, 18, 1261–1272.
To determine whether, compared to usual care, a mindfulness-based stress-reduction (MBSR) intervention involving breast cancer (BC) survivors is efficacious in improving psychological and physical status
Patients were randomized into one of two arms: the group receiving MBSR for BC patients (MBSR (BC)) and the group receiving usual care. Assignment to group was random and stratified by stage of cancer and treatment received; if desired, members of the usual-care group were wait-listed to receive the MBSR (BC) intervention. Assessments were completed at an initial baseline orientation and within two weeks of the end of the six-week intervention or control period. Data collectors were blinded to treatment assignment. The MBSR (BC) group received six weekly two-hour sessions led by a single trained psychologist. Class size was 4–8. Subjects received a training manual and four audiotapes to support home meditation practices. Members of the MBSR (BC) group kept a daily diary. Participants completed various activities during the six-week period. The intervention comprised three specific components:
Transition phase
Randomized controlled trial
Compared to usual care, the six-week MBSR (BC) program for BC survivors, within 18 months of treatment, resulted in significant improvements in psychological status and quality of life.
The symptoms this study addressed continue to be of great concern to patients with cancer. Nurses must know how to help patients with these symptoms during and after treatment. Nurses should explore alternative ways to educate patients about interventions that can improve outcomes.
Lengacher, C.A., Johnson-Mallard, V., Post-White, J., Moscoso, M.S., Jacobsen, P. B., Klein, T. W., . . . Kip, K.E. (2009). Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psycho-Oncology, 18, 1261–1272.
To determine if a mindfulness-based stress reduction (MBSR) intervention is effective in improving psychological and physical status in breast cancer survivors
The intervention was six group sessions of an MBSR program using meditation and body scan techniques. Participants received a training manual and audiotapes to support home practice of various forms of meditation and gentle yoga. The training manual included weekly objectives, exercises, program content, and a daily diary for recording practice activities.
A randomized controlled trial design was used.
Seventy percent of participants were determined to be compliant with the program. Intervention participants had better mean scores for state anxiety and depression compared to the control group at six weeks (p = 0.004; p = 0.03).
The MBSR program improved psychological distress, fear of recurrence, and quality of life among patients with breast cancer who recently transitioned from active treatment. The extent of practice of MBSR activities appears to influence the overall degree of benefit derived. A large percentage of patients were able to comply with a complex MBSR intervention.
Whether benefits seen were due to the actual intervention or the supportive aspects of the group was unable to be determined. More than half of eligible patients approached for enrollment declined due to scheduling issues, travel distance, lack of interest, and other issues. This suggests that such a program is limited in application related to these types of issues.
Lengacher, C.A., Shelton, M.M., Reich, R.R., Barta, M.K., Johnson-Mallard, V., Moscoso, M.S., . . . Kip, K.E. (2014). Mindfulness based stress reduction (MBSR [BC]) in breast cancer: Evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT). Journal of Behavioral Medicine, 37, 185–195.
To investigate the mechanisms of action of elements of mindfulness-based stress reduction (MBSR) that lead to specific clinical improvements, specifically to postulate and examine how changes in fear of recurrence as a result of participation in MBSR program may mediate a range of positive changes in psychological and physical symptoms and quality of life
At orientation, subjects were consented and randomized, and they completed baseline assessments. The assessments were completed again at two and six weeks following the MBSR program or control period. The program was adapted from the 1990 Jon Kabat-Zinn program. Subjects who were randomized to the MBSR group (n = 40) attended six, weekly, two-hour MBSR sessions with a trained psychologist. Participants learned four meditative practices, sitting meditation, walking meditation, body scan, and yoga, while integrating mindful attention to self-regulate and manage stressful symptoms. Participant materials included a training manual and audio tapes for home practice. Subjects completed a diary daily. Home meditation was advised for 15–45 minutes daily. The usual care (UC) group was offered the MBSR program after the six-week study period.
This was a randomized, controlled trial. Subjects were randomly assigned in a one-to-one ratio to either the MBSR or UC group. Randomization was stratified in an unblocked manner. Study personnel were blinded initially.
From baseline to six-weeks, the MBSR group experience more favorable changes than the UC group for several potential mediators including fear of recurrence concerns (2.8 versus .2, p = .007); fear of recurrence problems (11.4 versus .2, p = .02); depression (7.2 versus 4, p = .04); physical functioning (3.8 versus .5, p = .01) and energy (8.8 versus 5, p = .07). After removing direct effects of MBSR on outcomes of interest, the strongest and most consistent evidence for mediating effects (how MBSR works) was for change in fear of recurrence problems and change in physical functioning. The results indicate that MBSR is associated with reduced fear of recurrence and improved physical functioning which in turn are associated with reduced perceived stress and state and trait anxiety. The women in the UC group who experienced reduced fear of recurrence and improved physical functioning by mechanisms other than MBSR also experienced significantly reduced perceived stress and anxiety. Both groups experienced reduced anxiety and depression over time. There were no significant differences in anxiety between groups. Postintervention, the MBSR group had significantly higher depression scores (p = .04).
The fear of recurrence is highly prevalent in breast cancer survivors and is associated with considerable psychological distress. The results of this study may indicate that one of the mechanisms for how MBSR (BC) works is through the cognitive process of self-regulation of fear of recurrence to improve stress, anxiety, and physical functioning. The fear of recurrence influence by MBSR (BC) appeared to be reliable and clinically relevant. The findings did not demonstrate a direct effect on anxiety or depression scores.
The findings of this study show a clustering of multiple symptoms among breast cancer survivors. Interventions to simultaneously address multiple symptoms should be studied. MBSR is supported as being beneficial in reducing fear of recurrence and improving physical functioning. Training programs and awareness for nurses and staff members should be supported in cancer centers and survivorship programs.